۲ݮƵ

Academic and industry scientists collaborate on a new method to characterize research antibodies

Classified as: Peter McPherson, Carl Laflamme, Neuro
Published on: 18 Dec 2024

First Hybrid Workshop on Precision Health and Medicine

Synergizing our strengths in new technologies in omics, digital sciences, and translational medicine to advance patient care.

This event is organized in partnership between University of Bern and ۲ݮƵ University. This partnership between the universities aims to synergistically harness the power of new technologies in omics, digital sciences, and translational medicine to advance patient care.

Event details:

Category:
Published on: 25 Nov 2024

YCharOS antibody characterization platform addresses the “reproducibility crisis” in research

An innovative research project led by researchers at The Neuro has been awarded $1.5M by the Government of Quebec through CQDM.

YCharOS is an innovative platform led by neuroscientists Peter McPherson and Carl Laflamme that validates antibody reagents for human proteins.

Classified as: Peter McPherson, YCharos
Published on: 12 Nov 2024

Dear Colleagues,

Please see the next Medical Genetics Grand Rounds scheduled talk below:

Category:
Published on: 12 Nov 2024

We're happy to announce that the 2024 Amazing Brain Science Talks video recordings are officially live on our YouTube channel. Whether you're tuning in for the first time or revisiting your favourite moments, don't miss out on these compelling talks!

Published on: 11 Nov 2024

$1M grant from The Weston Family Foundation will pave the way for earlier intervention in REM sleep behaviour disorder and Parkinson’s disease

REM sleep behaviour disorder (RBD) is an often debilitating condition that causes people to act out in their sleep, sometimes violently. What’s worse, people with the disorder often go on to develop Parkinson’s disease.

Classified as: Ron Postuma, REM sleep behaviour disorder, Parkinson's, Neuro
Published on: 8 Nov 2024

Philippe Gros appointed Chief Scientific Officer of D2R

Philippe Gros has been appointed Chief Scientific Officer (CSO) of ۲ݮƵ’s DNA to RNA (D2R) Initiative, effective September 30, 2024. Prior to this role, he served as Deputy Vice-President (Research and Innovation) at ۲ݮƵ. This appointment follows a thorough international search, with the selection committee enthusiastic about their recommendation. Notably, Gros was instrumental in writing the application for the D2R Initiative, laying the groundwork for its success.

Category:
Published on: 31 Oct 2024

D2R welcomes RNA and genomic researchers to Université de Sherbrooke

Montreal – October 31, 2024 – ۲ݮƵ University’s DNA to RNA (D2R) research initiative is proud to announce the appointment of three new researchers at Université de Sherbrooke, marking the inaugural recipients of the D2R’s New Faculty Start-Up funding program. Université de Sherbrooke is a partner institution in the D2R initiative, working collaboratively to advance genomic and RNA research.

Category:
Published on: 31 Oct 2024

$1.14 million from CIHR will resolve treatment roadblocks for rare brain disorders

Gene therapy for rare neurological disorders will move one step forward thanks to a $1.14 million grant from the Canadian Institutes of Health Research (CIHR).

Classified as: Carl Ernst, rare diseases, ataxia, ACAR News
Published on: 23 Oct 2024

Thomas Durcan’s project will dissect the role of microglia in degenerative conditions, to identify new therapeutic strategies for Alzheimer's treatment

An innovative new program based at The Neuro has received $2.6 million from the CQDM and the Brain Canada Foundation.

Classified as: Neuro, Tom Durcan, Alzheimer's, ACAR News
Published on: 16 Oct 2024

MRI data from large sample shows increased whole-brain connectivity in people with a second language

Neuroplasticity is the brain’s ability to build connections within itself, adapting to the surrounding environment. The brain is most plastic in childhood, forming new pathways in reaction to stimuli such as language.

Classified as: Neuro, MNI, cognition, ACAR News
Published on: 11 Oct 2024

The 2024 Nobel Prize in Physiology or Medicine has been awarded to Victor Ambros and Gary Ruvkun for the discovery of microRNA and its role in post-transcriptional gene regulation.

Category:
Published on: 8 Oct 2024

RNA Nanotechnology - Gordon Research Conference (GRC)

Controlling RNA Sequence for Diagnostics and Therapeutic Delivery

January 5 - 10, 2025

Ventura, California, United States

Category:
Published on: 8 Oct 2024

Scientists use stem cells to follow development of protein bodies characteristic of neurological disease

Classified as: Peter McPherson, Parkinson's, Neuro, MNI
Category:
Published on: 8 Oct 2024

Congratulations to Dr. Raquel Cuella Martin on receiving the prestigious Gairdner Foundation Early Career Investigator Award.

As an Assistant Professor of Human Genetics at ۲ݮƵ University, Dr. Cuella Martin is pushing the boundaries of science with her lab, which uses precision genome editing to tackle complex biological problems.

Category:
Published on: 3 Oct 2024

Pages

Back to top